Citigroup’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-11,422
Closed -$950K 6156
2020
Q4
$950K Buy
11,422
+1,910
+20% +$139K ﹤0.01% 3592
2020
Q3
$442K Sell
9,512
-2,310
-20% -$219K ﹤0.01% 3960
2020
Q2
$1.46M Buy
11,822
+10,524
+811% +$1.2M ﹤0.01% 3155
2020
Q1
$138K Sell
1,298
-325
-20% -$58K ﹤0.01% 5059
2019
Q4
$419K Buy
1,623
+483
+42% +$180K ﹤0.01% 4585
2019
Q3
$601K Buy
1,140
+22
+2% +$16.3K ﹤0.01% 4175
2019
Q2
$1.05M Buy
1,118
+300
+37% +$301K ﹤0.01% 3555
2019
Q1
$888K Buy
+818
New +$732K ﹤0.01% 3541

Other funds holding ACB

Citigroup's ACB Position: Q1 2026 in Review

Citigroup reduced its Aurora Cannabis (ACB) stake by 72% in Q1 2026, selling an estimated $429K and leaving 43,523 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #4142.

Citigroup first reported a position in ACB in Q4 2018 and has held it in 24 quarters since. The position peaked at $1.4M in Q2 2019. 155 funds tracked by Wall St. Rank hold ACB as of Q1 2026.

  • Citigroup held 43,523 shares of Aurora Cannabis worth $143K as of Q1 2026.
  • Citigroup sold 113,497 Aurora Cannabis shares in Q1 2026, an estimated $429K.
  • Aurora Cannabis made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4142 holding.
  • Citigroup first reported a position in Aurora Cannabis in Q4 2018 and has held it in 24 quarters since.
  • Citigroup's Aurora Cannabis position peaked at $1.4M in Q2 2019.
  • 155 funds tracked by Wall St. Rank held Aurora Cannabis as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.